Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who are having surgery (either open surgery or a minimally invasive approach using a robot or small incisions) to remove the left part of the pancreas and the spleen at the same time, for a type of pancreatic cancer (called PDAC) that is located on the left side and is considered removable, borderline removable, or locally advanced
Who may not be able to join:
- People whose cancer has spread to or is directly touching the spleen
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jony van Hilst, MD, PhD, Amsterdam UMC, location University of Amsterdam, Department of Surgery, Amsterdam, The Netherlands
Phone: 0031617088813
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Lymph node metastasis in spleen-part
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.